Visit the Caliper Life Sciences web site

Latest news on Laboratorytalk categorised by product type

Contract research

Archive page 9 of 34

Our RSS feed for Contract research press releases

Rapid prototyping can save thousands

Independent Testing Laboratory has a state-of-the-art 3D modeller which can transform STL exported Cad drawings into an actual, functional prototype part at minimal cost in a fast turn-around time

News from Independent Testing Laboratory (24 October 2006)

Chiltern appoints UK medical director

Chiltern International, a global clinical research organisation, has strengthened its medical department with the appointment of Adrian Quartel as its new UK medical director

News from Chiltern International (19 October 2006)

EU directive on battery and accumulators

 Technical background article   The directive requires member states to take appropriate steps to ensure that spent batteries and accumulators are collected separately with a view to their recovery or disposal  Brochure available  

News from SGS (18 October 2006)

COSi exhibits in Asia for the first time

One of the leading European product innovators and contract manufacturers of cosmetics and toiletries will be attending the Cosmoprof exhibition in Hong Kong

News from COSi (10 October 2006)

£440,000 award from the UK National Health Service

The HTD scheme, which provides 50% funding, aims to stimulate new and innovative health care technologies designed to improve significantly the quality of healthcare in the United Kingdom

News from Acrongenomics (10 October 2006)

On track to meet targets for BioLED technology

Acrongenomics and Molecular Vision present an R+D update of their collaboration, following the meeting of the project's steering committee on 28 July 2006 at Molecular Vision's site in London

News from Acrongenomics (10 October 2006)

Chiltern appoints UK head of integrated resourcing

Chiltern International announces that Paul Westnedge has been appointed to head up Chiltern Integrated Resourcing Solutions (CIRS) UK

News from Chiltern International ( 5 October 2006)

Anti-cancer agent 'reduces breast tumour growth'

GTP-0805, when combined with tamoxifen and delivered orally, resulted in a 78 per cent reduction in breast tumour growth compared to a 21 per cent reduction when tamoxifen alone was administered

News from Phosphagenics (28 September 2006)

New director of finance and operations

Lipomics Technologies has announced that Scott Van Buskirk has joined the company in the newly created position of director of finance and operations

News from Lipomics Technologies (26 September 2006)

Dublin laboratory expansion for Icon

Icon Laboratories, a provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announces its expanded laboratory facilities in Dublin, Ireland

News from Icon (26 September 2006)

ClinPhone strengthens board with non-executives

ClinPhone has appointed Graeme Hart and Keith Bragman as non-executive directors, following the company's successful IPO launch on the London Stock Exchange in June 2006

News from ClinPhone (19 September 2006)

Application for HIV clinical trial in South Africa

 Technical background article   Virax has lodged a Clinical Trial Application (CTA) with the South African Medicines Control Council (MCC) for approval to conduct a Phase I/IIa trial of the VIR201 HIV vaccine

News from Virax Holdings (19 September 2006)

GRI celebrates 25th anniversary of first catalogue

GRI , a UK independent distributor of biotechnology products, has released its latest product portfolio to celebrate the 25th anniversary of its very first catalogue

News from GRI (18 September 2006)

Distributing ULS labelling system in UK and France

GRI and Kreatech Biotechnology have announced a partnership whereby GRI will exclusively supply Kreatech's Universal Linkage System (ULS) solutions to laboratories in the United Kingdom and France

News from GRI (18 September 2006)

Grant for lipid analysis fitness assessment study

Lipomics Technologies has been selected to receive a Phase II Small Business Technology Transfer Grant from the US Department of Defense to improve optimum fitness and performance of combat personnel

News from Lipomics Technologies (15 September 2006)

Key role in EU embryonal tumour pipeline project

Affitech selected to participate in European Union EET Pipeline project to identify fully human therapeutic antibody candidates for embryonal tumours (ET) using its unique antibody discovery platform

News from Affitech (14 September 2006)

Lipomics Technologies hires chief medical officer

Lipomics Technologies, specialising in the comprehensive and quantitative profiling of lipid metabolites, announced that Meeta Patnaik has joined in the newly created position of chief medical officer

News from Lipomics Technologies ( 8 September 2006)

Beware the plastic eating ants

 User application article   Ants that chew through plastic packaging were one of the more bizarre causes of pharmaceutical product failure that have been investigated by RSSL Pharma's Emergency Response Service in recent months

News from Reading Scientific Services ( 7 September 2006)

Key challenges facing drug accountability

Achieving comprehensive drug accountability documentation to ensure regulatory compliance is a major issue facing clinical trial sponsors

News from ClinPhone ( 6 September 2006)

Successful strategy prompts expansion

Looking to Europe has proved a successful strategy for Melbourn Scientific, a pharmaceutical contract research company which has grown by 30 per cent in the last 12 months

News from Melbourn Scientific ( 5 September 2006)

Earlier news from this category...
Latest news from this category...

 

Send us a blank email now to get our free regular email newsletter from the Editor
Laboratorytalk news by product category
Laboratorytalk news by date
Laboratorytalk news by manufacturer
Laboratorytalk Home Page

Register for the FREE Laboratorytalk email newsletter now! News about Contract research and more every issue. Click here for details.